Articles
16 June 2009
Vol. 2 No. 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006
https://doi.org/10.4081/hmr.v2i15.599

The molecular mechanisms of alkylating agent-related acute myeloid leukaemia

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
197
Views
1184
Downloads

Authors

James M. Allan
support@pagepress.org
Alkylating chemotherapy agents are used with considerable success to treat numerous human malignancies, including lung cancer, breast cancer, Hodgkin lymphoma and multiple myeloma. Alkylating agents encompass a broad range of structurally diverse agents that includes nitrogen mustards, methylating agents, platinating agents and nitrosoureas.

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



The molecular mechanisms of alkylating agent-related acute myeloid leukaemia. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.599